Post-approval studies (Phase 4)Ended earlyNCT04673175
What this trial is testing
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Who this might be right for
PneumoniaHematologic MalignancyPseudomonas Aeruginosa Infection+2 more
Weill Medical College of Cornell University 17